The global pressure ulcers treatment market was worth around USD 4.50 billion in 2021 and is estimated to grow to about USD 6.41 billion by 2028, with a compound annual growth rate (CAGR) of approximately 6.10 percent over the forecast period.
The global pressure ulcer treatment market was worth around USD 4.50 million in 2021 and is estimated to grow to about USD 6.41 million by 2028, with a compound annual growth rate (CAGR) of approximately 6.10 percent over the forecast period. The report analyzes the pressure ulcer treatment market’s drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the pressure ulcer treatment market.
The pressure ulcer treatment industry would benefit from increased awareness campaigns about the availability of various treatment methods. Because of increased skin fragility and thinning of the cell layers, as well as decreased capillary density and cell growth, the aging population is more sensitive to skin wounds, resulting in a delayed healing process. Pressure ulcers are projected to increase due to an aging population and obese patients. Rising red activities, significant unmet demands, and the advancement of therapy & diagnostic technologies will present the pressure ulcer treatment market with attractive chances. With a growing understanding of the adverse effects pressure ulcers have on patients' health and quality of life, the global market for pressure ulcer therapy is expected to increase significantly. Furthermore, as new technologies develop to assist the healthcare industry digital components of infection prevention systems are becoming increasingly popular.
The COVID-19 outbreak positively impacts the global pressure ulcer treatment market. With increased occurrences of obesity and overweight patients related to physical activity, the Covid-19 pandemic has driven global demand for pressure relief devices. Furthermore, strict lockdowns were employed extensively to eliminate the risk of Covid-19 infection, resulting in a higher healthy life, which has resulted in several lifestyle disorders such as overweight and cardiovascular disease, resulting in an increased supply of pressure relief devices globally.
Rising awareness is likely to pave the way for global market growth
A significant driver in the global market is increased awareness of pressure ulcers. Globally known entities committed to the prevention and treatment of pressure injuries, such as the National Pressure Injury Advisory Panel (NPIAP), have created prospects for growth in the market, lowering the burden of bed sores and prolonged hospital stays. Furthermore, government leaders in the Asia Pacific and the Middle East have supported MNCs and start-ups investing in the medical and biotechnology industries.
The high cost of treatment may hamper the market growth.
The high cost of pressure ulcer treatment is due to the use of high-tech technologies, which has a higher cost of maintenance in low-income countries, takes up critical nursing time, and has a massive effect on a hospital's performance ranking. As a result, treatment becomes increasingly unaffordable, which may limit the market expansion and pose significant challenges in the global pressure ulcer treatment market over the projection period.
Growing medical tourism practice to bring significant opportunities in the global market growth
Medical tourism also allows people to receive high-quality care in well-established medical facilities. Medical tourism is rapidly expanding in Asia. In developing countries, it is cost-effective and provides affordable treatment alternatives, prompt services, high-quality medical care & treatment facilities, well-connected planes, and excellent communication services. As medical tourism grows in undeveloped countries, there are more opportunities for selling pressure ulcer devices in those areas.
The global pressure ulcers treatment market is segregated based on wound, treatment, end-use, and region.
By wound, the market is classified into stage 1, stage 2, stage 3 and stage 4.
By treatment, the market is classified into inward pressure ulcers treatment and outward pressure ulcers treatment.
By end-use, the market is classified into hospital in-patient settings, hospital out-patient settings, community healthcare centers, and home care centres. The hospital in-patient settings segment dominates the market, accounting for more than 40 percent of global revenue. The hospital in-patient setting segment is expected to have a dominant pressure ulcer treatment market share during the forecast period due to higher adoption rates of pressure ulcer treatment options in hospitals, the presence of required facility skilled staff, and increasing patient preference for hospitals due to favorable policies.
|Historic Years||2016 - 2020|
|Forecast Years||2021 - 2028|
|Segments Covered||By Product Type, By Application, and By End Use|
|Forecast Units||Value (USD Billion), and Volume (Units)|
|Quantitative Units||Revenue in USD million/billion and CAGR from 2021 to 2028|
|Regions Covered||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World|
|Countries Covered||U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others|
|Number of Companies Covered||10 companies with scope for including additional 15 companies upon request|
|Report Coverage||Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.|
|Customization Scope||Avail customized purchase options to meet your exact research needs.|
Rising investments are likely to help North America dominate the global market
North America dominates the global pressure ulcers treatment market during the forecast period. Rising investments by market players in these regions, as well as clinical trials and pilot testing, are supporting the expansion of the pressure ulcer therapy sector in these areas. Furthermore, the country's high establishment of nursing care facilities has boosted the market position. The pressure ulcer treatment market in North America is expected to be driven by an older population and a high frequency of pressure ulcers among the elderly.
Asia Pacific regional market is expected to be the fastest-growing regional market due to increased domestic involvement, significant technological progress in the medical business, and better healthcare infrastructure. Furthermore, demand for sealants, devices, and dressings is expected to drive market expansion in the coming years.
Some of the main competitors dominating the global pressure ulcers treatment market include -"Smith & Nephew plc, Integra Life Sciences, Hill-Rom Holdings, Inc, Moonlike Health Care AB, Essity Katabolic, Cardinal Health, 3M, B. Braun Melungeon AG, Acuity L.P., Inc, Coloplast Group, Connate Group plc.
Pressure ulcers are projected to increase due to an aging population and obese patients. Rising Red activities, significant unmet demands, and the advancement of therapy and diagnostic technologies will present the pressure ulcer treatment market with attractive chances.
According to the report, the global Pressure Ulcers Treatment market was worth about 4.50 (USD million) in 2021 and is predicted to grow to around 6.41 (USD billion) by 2028, with a compound annual growth rate (CAGR) of about 6.10 percent.
North America dominates the Pressure Ulcers Treatment market. Rising investments by market players in these regions, as well as clinical trials and pilot testing, are supporting the expansion of the pressure ulcer therapy sector in these areas. Furthermore, the country's high establishment of nursing care facilities has boosted the market posture.
Some of the main competitors dominating the global Pressure Ulcers Treatment market include -"Smith & Nephew plc, Integra Life Sciences, Hill-Rom Holdings, Inc, Moonlike Health Care AB, Essity Katabolic, Cardinal Health, 3M, B. Braun Melungeon AG, Acuity L.P., Inc, Coloplast Group, Connate Group plc.